Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Bio-Path Holdings (BPTH) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 39 quarters since 2012. Compare with BPTH stock chart to see long term trends.

BPTH Stock Compared to Quarterly

BPTH Income Statement

Research & Development Expense:981000
Total Operating Expenses:2069000
Operating Income:-2069000
Net Income:-2069000
Earnings Per Share, Basic:-0.29
Shares Outstanding, Basic Avg:7160164

BPTH Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-2891000
Net Cash from Financing Activities:1399000
Net Change in Cash & Equivalents:-1492000

BPTH Balance Sheet

Cash and Cash Equivalents:26601000
Total Current Assets:30233000
Property, Plant & Equipment, Net:222000
Total Assets:30680000
Accounts Payable:417000
Total Short-Term Liabilities:1162000
Total Liabilities:1334000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group Inc
218,992 sh
 
$1,124
Blackrock Inc.
67,740 sh
-420 sh
-1%
$348
-$106
Geode Capital Management, LLC
65,783 sh
430 sh
1%
$337
-$98
Morgan Stanley
21,130 sh
19,830 sh
1525%
$108
$99
Northern Trust Corp
18,099 sh
355 sh
2%
$93
-$26
Dimensional Fund Advisors LP
15,375 sh
-12,773 sh
-45%
$79
-$109
Citadel Advisors LLC
12,404 sh
-12,952 sh
-51%
$64
-$105
State Street Corp
12,133 sh
 
$62
Tower Research Capital LLC (Trc)
1,405 sh
1,196 sh
572%
$7
$6
UBS Group Ag
806 sh
-3,292 sh
-80%
$4
-$23
Ironwood Financial, LLC
82 sh
 
$0
Crewe Advisors LLC
70 sh
 
$0
Global Retirement Partners, LLC
69 sh
 
$0
Wells Fargo & Company/Mn
43 sh
-2 sh
-4%
$0
Advisornet Financial, Inc
40 sh
 
$0
Bank Of America Corp /De/
22 sh
-62 sh
-74%
$0
Advisor Group Holdings, Inc.
14 sh
 
$0
Proequities, Inc.
0 sh
 
$0

Data imported from Bio-Path Holdings Inc. SEC filings. Check original filings before making any investment decision.